Use Able AI chat for product recommendations

Recombinant Mouse IL-7 protein (rFc Tag)

Species

Mouse

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg3825



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Mouse IL-7 protein Met+Glu26-Ile154 (Accession# Q544C8) with a rabbit IgG Fc tag at the C-terminus.
GeneID 16196
Accession Q544C8
PredictedSize 41.3 kDa
SDS-PAGE 45-52 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

IL-7 is one of the members of IL-2 superfamily. IL-7 is a hematopoietic growth factor secreted by stromal cells in the bone marrow and thymus. It is also produced by keratinocytes, dendritic cells, hepatocytes, neurons, and epithelial cells, but is not produced by normal lymphocytes. IL-7 plays an active role in the development, survival, maintaining and restoring homeostasis of mature T lymphocytes. It is also a key regulator of the commitment, survival, proliferation and maturation of B cells during development. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be a potent inducer of proinflammatory cytokines and chemokines which may defend against the infection, but may also mediate destructive lung injury. Elevated serum IL-7 levels, together with several other circulating cytokines and chemokines, has been found to be associated with the severity of Coronavirus Disease 19 (COVID-19).

References:

1. Steven A Corfe. et al. (2012) Semin Immunol. 24(3):198-208. 2. Sarah R Jacobs. et al. (2010) J Immunol. 184(7):3461-9. 3. C Heufler. et al. (1993) J Exp Med. 178(3):1109-14. 4. R Kröncke. et al. (1996) Eur J Immunol. 26(10):2541-4. 5. Yukihisa Sawa. et al. (2009) Immunity.30(3):447-57. 6. Pierre Francois Laterre. et al. (2020) JAMA Netw Open. 3(7):e2016485.

||
New chat

Able™

正在加载,请稍候...